Can't fill your Paxlovid 150 Mg /100 Mg Dose Pack prescription? Here are real alternative COVID-19 treatments your doctor may recommend in 2026.
Your doctor prescribed Paxlovid 150 Mg /100 Mg Dose Pack to treat your COVID-19 infection, but your pharmacy doesn't have it in stock. Or maybe a drug interaction makes Paxlovid unsafe for you. Either way, you're wondering: what are the alternatives?
The good news is that there are other FDA-approved and authorized treatments for COVID-19 in high-risk patients. In this article, we'll explain how Paxlovid works, why you might need an alternative, and what your doctor may recommend instead.
Paxlovid is an oral antiviral medication made by Pfizer. It combines two drugs:
The 150 Mg /100 Mg Dose Pack is the renal-adjusted dose, prescribed for patients with moderate kidney impairment (eGFR between 30 and 60 mL/min). The standard dose pack contains a higher amount of Nirmatrelvir (300 mg per dose).
Paxlovid is taken twice daily for 5 days and must be started within 5 days of COVID-19 symptom onset. It is approved for adults at high risk of progressing to severe disease.
When the SARS-CoV-2 virus infects your cells, it uses an enzyme called the main protease (Mpro) to process the proteins it needs to make copies of itself. Nirmatrelvir blocks this enzyme, effectively stopping the virus from multiplying.
Ritonavir doesn't fight the virus directly. Instead, it inhibits a liver enzyme called CYP3A4 that would normally break down Nirmatrelvir too quickly. By slowing this breakdown, Ritonavir keeps Nirmatrelvir levels high enough to be effective. This is the same reason Ritonavir is used as a booster in many HIV treatments.
However, this CYP3A4 inhibition is also why Paxlovid has so many drug interactions — it affects the metabolism of many other medications.
There are several reasons you might not be able to take Paxlovid:
Remdesivir, sold under the brand name Veklury, is an antiviral made by Gilead Sciences. It was the first FDA-approved treatment for COVID-19 and remains a first-line alternative to Paxlovid.
How it works: Remdesivir is a nucleotide analog that gets incorporated into the virus's RNA chain, causing premature termination of viral replication.
How it's given: For non-hospitalized patients, Remdesivir is administered as an IV infusion over 3 consecutive days at an outpatient infusion center. This is less convenient than taking pills at home, but it's effective and avoids the drug interaction concerns that come with Paxlovid.
Who it's for: Adults and pediatric patients (weighing at least 3.5 kg) with mild-to-moderate COVID-19 who are at high risk of severe disease. It can also be used in hospitalized patients.
Key advantage: Fewer drug interactions than Paxlovid, making it a good option for patients on complex medication regimens.
Molnupiravir, sold as Lagevrio, is an oral antiviral made by Merck. It is considered a second-line option — meaning doctors generally try Paxlovid or Remdesivir first.
How it works: Molnupiravir introduces errors into the virus's genetic code during replication, eventually making the virus unable to function. This mechanism is called "lethal mutagenesis."
How it's taken: Four 200 mg capsules taken by mouth twice daily for 5 days (800 mg twice daily).
Who it's for: Adults with mild-to-moderate COVID-19 who are at high risk of progressing to severe disease and for whom other authorized treatments are not accessible or appropriate.
Key considerations: Clinical trials showed Molnupiravir was less effective than Paxlovid at reducing hospitalization and death. It is not recommended for use during pregnancy due to potential risks to the fetus.
If your COVID-19 symptoms progress to severe illness and you haven't been able to access antiviral treatment, you may need hospital-based care. In the hospital setting, treatments may include:
This is a decision to make with your doctor. Factors that influence the choice include:
Don't try to self-prescribe or choose an alternative on your own. Talk to your healthcare provider about what's safest and most effective for your situation.
Paxlovid 150 Mg /100 Mg Dose Pack is the preferred first-line oral treatment for COVID-19 in high-risk patients, but it's not your only option. Remdesivir (Veklury) is an effective IV alternative with fewer drug interactions, and Molnupiravir (Lagevrio) is an oral backup when other treatments aren't available.
If you're having trouble finding Paxlovid, try Medfinder to check pharmacy availability before switching to an alternative. And if you do need a different treatment, your doctor can help you choose the safest option. For more information, read our guides on what Paxlovid is and how it works and how to find Paxlovid in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
